UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549
                                  _____________

                                    Form 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     Date of Report (Date of earliest event reportedly): December 23, 2008

                              OCEAN BIO-CHEM, INC.
               (Exact name of registrant as specified in charter)

      Florida                            2-11102                    59-1564329
(State or Other Jurisdiction     (Commission File Number)      (I.R.S. Employer
of Incorporation)                                            Identification No.)

               4041 S.W. 47 Avenue, Fort Lauderdale, Florida 33314
                (Address of principal executive office Zip Code)

                                 (954) 587-6280
               Registrants telephone number, including area code:

                                 Not Applicable
          (Former name or former address, if changes since last report)

     Check the  appropriate  box below if the Form 8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

     [ ] Written  communications  pursuant to Rule 425 under the  Securities Act
(17 CFR 230.425)

     [ ] Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)

     [ ]  Pre-commencement  communications  pursuant to Rule 14d-2(b)  under the
Exchange Act (17 CFR 240.14d-2(b))

     [ ]  Pre-commencement  communications  pursuant to Rule 13e-4(c)  under the
Exchange Act (17 CFR 240.13e-4(c))




     Item 7.01 Regulation FD

     On  December  23,  2008,  the  Company  received   notification   from  its
Re-marketing  Agent that its City of Montgomery,  AL Series 1997 and Series 2002
Industrial  Revenue Bonds with an approximate  aggregate  balance of $3,825,000,
were sold to various  bondholders.  As  previously  disclosed,  these bonds were
tendered back to the Company during October 2007 resulting in a default interest
rate of approximately 7% per annum. As a result of the re-marketing, the current
interest rate is  approximately  2% per annum and will adjust  weekly,  based on
prevailing trends in the tax exempt interest market.  These bonds continue to be
backed with a Letter of Credit from Regions Bank.  Under the terms of the Letter
of Credit, Regions Bank is obligated to pay the bondholders,  if tendered. There
has been no default on these bonds. It is our understanding that this tender was
the result of liquidity needs of the various  bondholders.  The  re-marketing of
the bonds is  indicative  of the  public's  confidence  in the  Company  and its
lender, Regions Bank.

                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

December 24, 2008
                                      Ocean Bio-Chem, Inc.


                                      /s/ Jeffrey S. Barocas
                                      Jeffrey S. Barocas
                                      Vice President - Finance and
                                      Chief Financial Officer